Skip to main content
SpringerLink
Log in

Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) is a common co-morbidity among patients undergoing Transcatheter Aortic Valve Implantation (TAVI). Only recently have the clinical outcomes of patients with chronic or new-onset AF after TAVI been reported. The absence of clinical trials focusing on this cohort of patients has resulted in the lack of evidence based clinical guidelines. We aim to review and discuss the current literature on AF in TAVI, its clinical implications and future perspectives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Falk RH (2001) Atrial fibrillation. N Engl J Med 344:1067–1078

    Article  PubMed  CAS  Google Scholar 

  2. Chugh SS, Blackshear JL, Shen WK et al (2001) Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37:371–378

    Article  PubMed  CAS  Google Scholar 

  3. Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375

    Article  PubMed  CAS  Google Scholar 

  4. Heeringa J, van der Kuip DA, Hofman A et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953

    Article  PubMed  Google Scholar 

  5. Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461

    Article  PubMed  CAS  Google Scholar 

  6. Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. First human case description. Circulation 106:3006–3008

    Article  PubMed  Google Scholar 

  7. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  PubMed  CAS  Google Scholar 

  8. Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  PubMed  CAS  Google Scholar 

  9. Rodes-Cabau J (2012) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29

    Article  Google Scholar 

  10. Rodes-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080–1090

    Article  PubMed  Google Scholar 

  11. Piazza N, Grube E, Gerckens U et al (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4:242–249

    Article  PubMed  Google Scholar 

  12. Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299–308

    Article  PubMed  Google Scholar 

  13. Bosmans JM, Kefer J, de Bruyne B et al (2011) Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 12:762–767

    Article  PubMed  Google Scholar 

  14. Gilard M, Eltchaninoff H, Iung B et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715

    Article  PubMed  CAS  Google Scholar 

  15. Motloch LJ, Reda S, Rottlaender D et al (2011) Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 93:124–131

    Article  PubMed  Google Scholar 

  16. Amat-Santos IJ, Rodes-Cabau J, Urena M et al (2012) Incidence, predictive factors and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 59:178–188

    Article  PubMed  CAS  Google Scholar 

  17. Nuis RJ, Van Mieghem NM, Schultz CJ et al (2012) Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 109:1637–1643

    Article  PubMed  Google Scholar 

  18. Linke A (2012). Treatment of high risk aortic stenosis patients with transcatheter Medtronic CoreValve implantation. CoreValve ADVANCE. Paper presented at Transcatheter Valve Therapies, 2–5 June 2012

  19. Wendler O (2012). 30-day outcome from the SOURCE XT TAVI post-approval study. Paper presented at EuroPCR 2012

  20. Shahian DM, O’Brien SM, Filardo G et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1—coronary artery bypass grafting surgery. Ann Thorac Surg 88:S2–S22

    Article  PubMed  Google Scholar 

  21. Faxon DP, Eikelboom JW, Berger PB et al (2011) Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. Thromb Haemost 106:572–584

    Article  PubMed  CAS  Google Scholar 

  22. Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844

    Article  PubMed  CAS  Google Scholar 

  23. Cox JL (1993) A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 56:405–409

    Article  PubMed  CAS  Google Scholar 

  24. Mehta RH, Dabbous OH, Granger CB et al (2003) Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 92:1031–1036

    Article  PubMed  Google Scholar 

  25. Al-Khatib SM, Pieper KS, Lee KL et al (2001) Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol 88:76–79

    Article  Google Scholar 

  26. Lau DH, Huynh LT, Chew DP et al (2009) Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 104:1317–1323

    Article  PubMed  Google Scholar 

  27. Kinjo K, Sato H, Sato H et al (2003) Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 92:1150–1154

    Article  PubMed  Google Scholar 

  28. Bramer S, van Straten AH, Soliman Hamad MA et al (2010) The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg 90:443–449

    Article  PubMed  Google Scholar 

  29. Mariscalco G, Klersy C, Zanobini M et al (2008) Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 118:1612–1618

    Article  PubMed  Google Scholar 

  30. Saxena A, Dinh DT, Smith JA et al (2012) Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol 109:219–225

    Article  PubMed  Google Scholar 

  31. Lehto M, Snapinn S, Dickstein K et al (2005) Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 26:350–356

    Article  PubMed  Google Scholar 

  32. Kappetein AP, Head SJ, Genereux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve replacement: the valve academic research consortium-2 consensus document. J Am Coll Cardiol 60:1438–1454

    Article  PubMed  Google Scholar 

  33. Frost L, Molgaard H, Christiansen EH et al (1992) Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol 36:253–261

    Article  PubMed  CAS  Google Scholar 

  34. Holmes DR, Mack MJ, Kaul S et al (2012) ACCF/AATS/SCAI/STS Expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59:1200–1254

    Article  PubMed  Google Scholar 

  35. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9N

    Article  PubMed  CAS  Google Scholar 

  36. Eltchaninoff H, Prat A, Gilard M et al (2011) Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32:191–197

    Article  PubMed  Google Scholar 

  37. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U (2012) Post-operative atrial fibrillation: a maze of mechanisms. Europace 14:159–174

    Article  PubMed  Google Scholar 

  38. O’Brien B, Pasic M, Kuppe H, Hetzer R, Habazetti H, Kukucka M (2011) A transapical or transluminal approach to aortic valve implantation does not attenuate the inflammatory response. Heart Surg Forum 14:E110–E113

    Article  PubMed  Google Scholar 

  39. Rodes-Cabau J, Webb JG, Cheung A et al (2012) Long-term outcomes following transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 60:1864–1875

    Article  PubMed  Google Scholar 

  40. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH (2012) Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8:129–138

    Article  PubMed  Google Scholar 

  41. Hynes BG, Rodés-Cabau J (2012) Transcatheter aortic valve implantation and cerebrovascular events: the current state of the art. Ann N Y Acad Sci 1254:151–163

    Article  PubMed  Google Scholar 

  42. Nombela-Franco L, Webb J, de Jaegere P et al (2012) Timing, predictive factors and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126:3041–3053

    Article  PubMed  Google Scholar 

  43. Schroeter T, Linke A, Haensig M et al (2012) Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace 14:1759–1763

    Article  PubMed  Google Scholar 

  44. Neumar RW, Otto CW, Link MS et al (2010) Part 8: adult advanced cardiovascular life support. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 122(Suppl 3):S729–S767

    Article  PubMed  Google Scholar 

  45. Webb J, Rodes-Cabau J, Fremes S et al (2012) Transcatheter aortic valve implantation: a Canadian cardiovascular society position statement. Can J Cardiol 28:520–528

    Article  PubMed  Google Scholar 

  46. Ussia GP, Scarabelli M, Mule M et al (2011) Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108:1772–1776

    Article  PubMed  CAS  Google Scholar 

  47. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  PubMed  CAS  Google Scholar 

  48. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891

    Article  PubMed  CAS  Google Scholar 

  49. Lip GY (2011) Implications of the CHA(2)DS(2)-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation. Am J Med 124:111–114

    Article  PubMed  Google Scholar 

  50. Zeymer U, Zahn R, Gerckens U et al (2011) Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J 32(Abstract suppl):900

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, QC, G1V4G5, Canada

    Michael Mok, Marina Urena, Luis Nombela-Franco, Henrique Barbosa Ribeiro, Ricardo Allende, Robert DeLarochellière, Daniel Doyle, Eric Dumont, Mélanie Côté & Josep Rodés-Cabau

Authors
  1. Michael Mok
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Urena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Nombela-Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henrique Barbosa Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ricardo Allende
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert DeLarochellière
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniel Doyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eric Dumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mélanie Côté
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Josep Rodés-Cabau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josep Rodés-Cabau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mok, M., Urena, M., Nombela-Franco, L. et al. Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation. J Thromb Thrombolysis 35, 450–455 (2013). https://doi.org/10.1007/s11239-012-0859-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0859-7

Keywords

Search

Navigation